Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica L Beatson

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
American Journal of Clinical and Experimental Urology|September 2, 2022
PARP inhibitors on the move in prostate cancer: spotlight on Niraparib & update on PARP inhibitor combination trialsErica L Beatson, Cindy H Chau, Douglas K Price, et al.
Journal of Racial and Ethnic Health Disparities|February 22, 2023
Bridging Health Disparities: a Genomics and Transcriptomics Analysis by Race in Prostate CancerKristi Y Lee, Erica L Beatson, Seth M Steinberg, et al.
International Journal of Molecular Sciences|June 19, 2024
Genomic Characterization of Preclinical Prostate Cancer Cell Line ModelsErica L Beatson, Emily N Risdon, Giulia C Napoli, et al.
The Lancet. Oncology|December 5, 2024
Navigating the oncology drug discovery and development process with programmes supported by the National Institutes of HealthOluwatobi T Arisa, Erica L Beatson, Annieka Reno, et al.
Journal of Cancer|January 12, 2024
Detection of Extracellular Vesicle-Derived RNA as Potential Prostate Cancer Biomarkers: Role of Cancer-type SLCO1B3 and ABCC3Kristi Y Lee, Erica L Beatson, Martina A Knechel, et al.
Cancer Research Communications|July 24, 2025
Direct Co-Targeting of Bcl-xL and Mcl-1 Exhibits Synergistic Effects in AR-V7-Expressing CRPC ModelsBenjamin C Brim, Andres F Leon, Erica L Beatson, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Co-Targeting Nuclear Export and Translation Initiation Uncovers a Therapeutic Vulnerability in Lethal Prostate CancerJessica D Kindrick, Kinjal Bhadresha, Xiaohu Zhang, et al.
Nature Communications|October 8, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancerJuan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
American Journal of Clinical and Experimental Urology|September 2, 2022
PARP inhibitors on the move in prostate cancer: spotlight on Niraparib & update on PARP inhibitor combination trialsErica L Beatson, Cindy H Chau, Douglas K Price, et al.
Journal of Racial and Ethnic Health Disparities|February 22, 2023
Bridging Health Disparities: a Genomics and Transcriptomics Analysis by Race in Prostate CancerKristi Y Lee, Erica L Beatson, Seth M Steinberg, et al.
International Journal of Molecular Sciences|June 19, 2024
Genomic Characterization of Preclinical Prostate Cancer Cell Line ModelsErica L Beatson, Emily N Risdon, Giulia C Napoli, et al.
The Lancet. Oncology|December 5, 2024
Navigating the oncology drug discovery and development process with programmes supported by the National Institutes of HealthOluwatobi T Arisa, Erica L Beatson, Annieka Reno, et al.
Journal of Cancer|January 12, 2024
Detection of Extracellular Vesicle-Derived RNA as Potential Prostate Cancer Biomarkers: Role of Cancer-type SLCO1B3 and ABCC3Kristi Y Lee, Erica L Beatson, Martina A Knechel, et al.
Cancer Research Communications|July 24, 2025
Direct Co-Targeting of Bcl-xL and Mcl-1 Exhibits Synergistic Effects in AR-V7-Expressing CRPC ModelsBenjamin C Brim, Andres F Leon, Erica L Beatson, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Co-Targeting Nuclear Export and Translation Initiation Uncovers a Therapeutic Vulnerability in Lethal Prostate CancerJessica D Kindrick, Kinjal Bhadresha, Xiaohu Zhang, et al.
Nature Communications|October 8, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancerJuan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo, et al.
Pageof 1